𝔖 Bobbio Scriptorium

✦ LIBER ✦

POD-6.07: Surgical Morbidity Associated with Administration of Targeted Molecular Therapies Prior to Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma

✍ Scribed by C. Wood; V. Margulis; S. Matin; P. Tamboli; D. Swanson

Book ID: 116949717
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 57 KB
Volume: 72
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2008.08.123

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: Surgical Morbidity Associated with A

Re: Surgical Morbidity Associated with Administration of Targeted Molecular Therapies before Cytoreductive Nephrectomy or Resection of Locally Recurrent Renal Cell Carcinoma

✍ Robert C. Flanigan; Anthony Pulcari 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Corrigendum to: “Re: Surgical Morbidity

Corrigendum to: “Re: Surgical Morbidity Associated with Administration of Targeted Molecular Therapies before Cytoreductive Nephrectomy or Resection of Locally Recurrent Renal Cell Carcinoma” [Eur Urol 2009;55:990–1]

✍ Robert C. Flanigan; Anthony Polcari 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Surgical morbidity associated with admin

Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma: Margulis V, Matin SF, Tannir N, Tamboli P, Swanson DA, Jonasch E, Wood CG, Department of Urology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX

✍ Michael L. Blute 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 86 KB